CFDE Associated and Common Fund Programs’ Landmark Publications

Fisher JL; Wilk EJ; Oza VH; Gary SE; Howton TC; Flanary VL; Clark AD; Hjelmeland AB; Lasseigne BN. 2024. Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates.Febs Open Bio. 14. 803-830 https://www.doi.org/$10.1002/2211-5463.13796
R03

Shahneh MRZ; Strobel M; Vitale GA; Geibel C; Abiead YE; Garg N; Wagner B; Forchhammer K; Aron A; Phelan VV; Petras D; Wang M. 2024. ModiFinder: Tandem Mass Spectral Alignment Enables Structural Modification Site Localization.Journal Of The American Society For Mass Spectrometry. 35. 2564-2578 https://www.doi.org/$10.1021/jasms.4c00061

AI-READI Consortium. 2024. AI-READI: rethinking AI data collection, preparation and sharing in diabetes research and beyond.Nature Metabolism. . https://www.doi.org/$/10.1038/s42255-024-01165-x
Landmark
Bridge2AI

Fisher JL; Clark AD; Jones EF; Lasseigne BN. 2024. Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes.Bmc Pharmacology & Toxicology. 25. 5 https://www.doi.org/$10.1186/s40360-023-00727-1
R03

Beaven E; Kumar R; An JM; Mendoza H; Sutradhar SC; Choi W; Narayan M; Lee YK; Nurunnabi M. 2024. Potentials of ionic liquids to overcome physical and biological barriers.Advanced Drug Delivery Reviews. 204. 115157 https://www.doi.org/$10.1016/j.addr.2023.115157
R03

Diwan R; Gaytan SL; Bhatt HN; Pena-Zacarias J; Nurunnabi M. 2024. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities.Drug Delivery And Translational Research. 14. 2743-2770 https://www.doi.org/$10.1007/s13346-024-01551-8

MoTrPAC Study Group, Lead Analysts, MoTrPAC Study Group. 2024. Temporal dynamics of the multi-omic response to endurance exercise training.Nature. 629. 174-183 https://www.doi.org/$10.1038/s41586-023-06877-w
MoTrPAC

Suryadevara V, Hudgins AD, Rajesh A, Pappalardo A, Karpova A, Dey AK, Hertzel A, Agudelo A, Rocha A, Soygur B, Schilling B, Carver CM, Aguayo-Mazzucato C, Baker DJ, Bernlohr DA, Jurk D, Mangarova DB, Quardokus EM, Enninga EAL, Schmidt EL, Chen F, Duncan FE, Cambuli F, Kaur G, Kuchel GA, Lee G, Daldrup-Link HE, Martini H, Phatnani H, Al-Naggar IM, Rahman I, Nie J, Passos JF, Silverstein JC, Campisi J, Wang J, Iwasaki K, Barbosa K, Metis K, Nernekli K, Niedernhofer LJ, Ding L, Wang L, Adams LC, Ruiyang L, Doolittle ML, Teneche MG, Schafer MJ, Xu M, Hajipour M, Boroumand M, Basisty N, Sloan N, Slavov N, Kuksenko O, Robson P, Gomez PT, Vasilikos P, Adams PD, Carapeto P, Zhu Q, Ramasamy R, Perez-Lorenzo R, Fan R, Dong R, Montgomery RR, Shaikh S, Vickovic S, Yin S, Kang S, Suvakov S, Khosla S, Garovic VD, Menon V, Xu Y, Song Y, Suh Y, Dou Z, Neretti N. 2024. SenNet recommendations for detecting senescent cells in different tissues.Nature Reviews Molecular Cell Biology. . https://www.doi.org/$10.1038/s41580-024-00738-8
Landmark
SenNet

Li X; Zhou Chen Y; Kalia A; Zhu H; Liu LP; Hassoun S. 2024. An Ensemble Spectral Prediction (ESP) model for metabolite annotation.Bioinformatics (oxford, England). 40. https://www.doi.org/$10.1093/bioinformatics/btae490
R03

Liu YA; Aboud O; Dahabiyeh LA; Bloch O; Fiehn O. 2024. Metabolomic characterization of human glioblastomas and patient plasma: a pilot study.F1000research. 13. 98 https://www.doi.org/$10.12688/f1000research.143642.3
R03

Rows per page:

1–10 of 80

@CFDE Workbench 2024
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.



The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
@CFDE Workbench 2024